{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T00:24:58Z","timestamp":1707006298172},"reference-count":21,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2024,1,31]]},"DOI":"10.1536\/ihj.23-389","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T22:17:33Z","timestamp":1706653053000},"page":"21-28","source":"Crossref","is-referenced-by-count":0,"title":["Pretransfer Aspirin Administration and Its Impact on Angiographic Outcomes for Patients with ST-Elevation Myocardial Infarction"],"prefix":"10.1536","volume":"65","author":[{"given":"Ryota","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Horikoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamitsu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Uematsu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kobayahi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yoshizaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Kuroki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuto","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, University of Yamanashi, Faculty of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ibanez B, James S, Agewall S, <i>et al<\/i>. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017; 39: 119-77.","DOI":"10.1093\/eurheartj\/ehx393"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kimura K, Kimura T, Ishihara M, <i>et al<\/i>. JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome. Circ J 2019; 83: 1085-196.","DOI":"10.1253\/circj.CJ-19-0133"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Levine GN, Bates ER, Bittl JA, <i>et al<\/i>. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for Percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation 2016; 134: e123-55.","DOI":"10.1161\/CIR.0000000000000404"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Stone GW, Cox D, Garcia E, <i>et al<\/i>. Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation 2001; 104: 636-41.","DOI":"10.1161\/hc3101.093701"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. He S, Blomback M, Yoo G, Sinha R, Henschen-Edman AH. Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system. Ann N Y Acad Sci 2001; 936: 531-5.","DOI":"10.1111\/j.1749-6632.2001.tb03540.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Henschen-Edman AH. Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease. Ann N Y Acad Sci 2001; 936: 580-93.","DOI":"10.1111\/j.1749-6632.2001.tb03546.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wood AJJ, Patrono C. Aspirin as an antiplatelet drug. N Engl J Med 1994; 330: 1287-94.","DOI":"10.1056\/NEJM199405053301808"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Beygui F, Castren M, Brunetti ND, <i>et al<\/i>. Pre-hospital management of patients with chest pain and\/or dyspnoea of cardiac origin. A position paper of the acute cardiovascular care association (ACCA) of the ESC. Eur Heart J Acute Cardiovasc Care 2020; 9: 59-81.","DOI":"10.1177\/2048872615604119"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Nakayama N, Yamamoto T, Kikuchi M, <i>et al<\/i>. Prehospital administration of aspirin and nitroglycerin for patients with suspected acute coronary syndrome- a systematic review. Circ Rep 2022; 4: 449-57.","DOI":"10.1253\/circrep.CR-22-0060"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Millin MG, Brooks SC, Travers A, <i>et al<\/i>. Emergency medical services management of ST-elevation myocardial infarction. Prehosp Emerg Care 2008; 12: 395-403.","DOI":"10.1080\/10903120802099310"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Quan D, LoVecchio F, Clark B, Gallagher JV 3rd. Prehospital use of aspirin rarely is associated with adverse events. Prehosp Disaster Med 2004; 19: 362-5.","DOI":"10.1017\/S1049023X00001990"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Zijlstra F, Ernst N, de Boer MJ, <i>et al<\/i>. Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol 2002; 39: 1733-7.","DOI":"10.1016\/S0735-1097(02)01856-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nammas W, Pietila M, Romppanen H, Sia J, DeBelder A, Karjalainen PP. Outcome of poor initial TIMI flow in patients presenting with acute coronary syndrome. Scand Cardiovasc J 2017; 51: 248-54.","DOI":"10.1080\/14017431.2017.1346278"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Rakowski T, Dudek D, Dziewierz A, <i>et al<\/i>. Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial. Eurointervention 2013; 8: 1307-14.","DOI":"10.4244\/EIJV8I11A199"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Brener SJ, Mehran R, Brodie BR, <i>et al<\/i>. Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI trials). Am J Cardiol 2011; 108: 918-23.","DOI":"10.1016\/j.amjcard.2011.05.022"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Joost A, Stiermaier T, Eitel C, <i>et al<\/i>. Impact of initial culprit vessel flow on infarct size, microvascular obstruction, and myocardial salvage in acute reperfused ST-elevation myocardial infarction. Am J Cardiol 2016; 118: 1316-22.","DOI":"10.1016\/j.amjcard.2016.07.056"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Schaaf MJ, Mewton N, Rioufol G, <i>et al<\/i>. Pre-PCI angiographic TIMI flow in the culprit coronary artery influences infarct size and microvascular obstruction in STEMI patients. J Cardiol 2016; 67: 248-53.","DOI":"10.1016\/j.jjcc.2015.05.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. De Luca G, Ernst N, van&apos;t Hof AWJ, <i>et al<\/i>. Preprocedural thrombolysis in myocardial infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplasty. Am Heart J 2005; 150: 827-31.","DOI":"10.1016\/j.ahj.2004.12.030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakashima T, Tahara Y. Achieving the earliest possible reperfusion in patients with acute coronary syndrome: a current overview. J Intensive Care 2018; 6: 20.","DOI":"10.1186\/s40560-018-0285-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Krishnamoorthy P, Vengrenyuk A, Wasielewski B, <i>et al<\/i>. Mobile application to optimize care for ST-segment elevation myocardial infarction patients in a large healthcare system, STEMIcathAID: rationale and design. Eur Heart J Digit Health 2021; 2: 189-201.","DOI":"10.1093\/ehjdh\/ztab010"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lippi G, Danese E, Favaloro EJ. Harms and benefits of using aspirin for primary prevention of cardiovascular disease: a narrative overview. Semin Thromb Hemost 2019; 45: 157-63.","DOI":"10.1055\/s-0038-1675380"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-389\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T04:11:11Z","timestamp":1706933471000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/65\/1\/65_23-389\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,31]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.23-389","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,31]]},"article-number":"23-389"}}